1) Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96:614-8.
2) Hollands H, Johnson D, Hollands S, et al. Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA 2013;309:2035-42.
4) Park BJ, Park JO, Kang HT, Lee YJ. Elevated intraocular pressure is associated with metabolic syndrome in postmenopausal women: the Korean National Health and Nutrition Examination Survey. Menopause 2013;20:742-6.
5) Newman-Casey PA, Talwar N, Nan B, et al. The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmology 2011;118:1318-26.
6) Poh S, Mohamed Abdul RB, Lamoureux EL, et al. Metabolic syndrome and eye diseases. Diabetes Res Clin Pract 2016;113:86-100.
8) Kang BM, Koo YH, Lee SR, et al. Association between serum estradiol level and intraocular pressure in postmenopausal women. J Reprod Med 2009;54:483-7.
10) Park SS, Lee EH, Jargal G, et al. The distribution of intraocular pressure and its association with metabolic syndrome in a community. J Prev Med Public Health 2010;43:125-30.
11) Wen CP, David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr 2009;12:497-506.
12) Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
14) Kim M, Jeoung JW, Park KH, et al. Metabolic syndrome as a risk factor in normal-tension glaucoma. Acta Ophthalmol 2014;92:e637-43.
15) Zhang Y, Zhang Q, Thomas R, et al. Association of hypertriglyceridemia and incident glaucoma in a rural Chinese population: the Handan Eye Study. Transl Vis Sci Technol 2021;10:25.
16) Głowińska B, Urban M, Hryniewicz A, et al. Endothelin-1 plasma concentration in children and adolescents with atherogenic risk factors. Kardiol Pol 2004;61:329-38.
20) Yi YH, Cho YH, Kim YJ, et al. Metabolic syndrome as a risk factor for high intraocular pressure: the Korea National Health and Nutrition Examination Survey 2008-2010. Diabetes Metab Syndr Obes 2019;12:131-7.
23) McCann P, Hogg RE, Fallis R, Azuara-Blanco A. The effect of statins on intraocular pressure and on the incidence and progression of glaucoma: a systematic review and meta-analysis. Invest Ophthalmol Vis Sci 2016;57:2729-48.
24) Song J, Deng PF, Stinnett SS, et al. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci 2005;46:2424-32.
25) Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002;21:359-93.
26) Grieshaber MC, Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol 2005;16:79-83.
28) Szaflik JP, Rusin P, Zaleska-Zmijewska A, et al. Reactive oxygen species promote localized DNA damage in glaucoma-iris tissues of elderly patients vulnerable to diabetic injury. Mutat Res 2010;697:19-23.
29) Tielsch JM, Katz J, Sommer A, et al. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995;113:216-21.
30) Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 2001;119:1819-26.
31) Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002 120:714-20. discussion 829-30.
32) Leske MC, Wu SY, Nemesure B, Hennis A. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol 2002;120:954-9.
33) Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000;107:1287-93.
34) Choi J, Jeong J, Cho HS, Kook MS. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci 2006;47:831-6.
36) Caprioli J, Coleman AL. Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol 2010;149:704-12.
37) Graham SL, Butlin M, Lee M, Avolio AP. Central blood pressure, arterial waveform analysis, and vascular risk factors in glaucoma. J Glaucoma 2013;22:98-103.
38) Ramdas WD, Wolfs RC, Hofman A, et al. Lifestyle and risk of developing open-angle glaucoma: the Rotterdam study. Arch Ophthalmol 2011;129:767-72.
40) Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583-7.
42) Christakis MK, Hasan H, De Souza LR, Shirreff L. The effect of menopause on metabolic syndrome: cross-sectional results from the Canadian Longitudinal Study on Aging. Menopause 2020;27:999-1009.
43) Zhou X, Li F, Ge J, et al. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma. Dev Neurobiol 2007;67:603-16.
45) Deschênes MC, Descovich D, Moreau M, et al. Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 2010;51:2587-600.
46) Kim CS, Seong GJ, Lee NH, et al. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology 2011;118:1024-30.
47) Caprioli J, Spaeth GL. Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Am J Ophthalmol 1984;97:730-7.